Chitooligosaccharides prevent osteopenia by promoting bone formation and suppressing bone resorption in ovariectomised rats: Possible involvement of COX-2

Natural Product Research

Volumn 29, Issue 4, 2015, Pages 359-362

  He, Bingshu ^a   Wang, Jun ^b  

^a Department of Orthopedic Surgery Hubei Woman and Child Hospital ^*  (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

chitooligosaccharides; cyclooxygenase 2; osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME 5B; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENT; CALCIUM ION; CARBOXY TERMINAL TELOPEPTIDE; CHITIN DERIVATIVE; CHITOOLIGOSACCHARIDE; COLLAGEN TYPE 1; CYCLOOXYGENASE 2; ESTRADIOL; MESSENGER RNA; OLIGOSACCHARIDE; OSTEOCALCIN; UNCLASSIFIED DRUG; CHITIN; PTGS2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE STRENGTH; BONE TURNOVER; CALCIUM INTAKE; CONTROLLED STUDY; DETERIORATION; DOWN REGULATION; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; FEMUR; FEMUR METAPHYSIS; IN VITRO STUDY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; TRABECULAR BONE; UPREGULATION; ANIMAL; BONE DISEASES, METABOLIC; DRUG EFFECTS; METABOLISM;

ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; CHITIN; CYCLOOXYGENASE 2; FEMALE; OLIGOSACCHARIDES; OSTEOPOROSIS; OVARIECTOMY; RATS;

EID: 84920564608     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2014.942301     Document Type: Article

References (13)

1. Fernandes JC, Spindola H, de Sousa V, Santos-Silva A, Pintado ME, Malcata FX, Carvalho JE. 2010. Anti-inflammatory activity of chitooligosaccharides in vivo. Mar Drugs. 8:1763-1768.
2. Guo Y, Zhang CY, Tian Y, DI JM, Qin S. 2012. Effect of cyclooxygenase-2 on bone loss in ovariectomized rats. Zhonghua Fu Chan Ke Za Zhi. 47:458-462.
3. Jung WK, Moon SH, Kim SK. 2006. Effect of chitooligosaccharides on calcium bioavailability and bone strength in ovariectomized rats. Life Sci. 78:970-976.
4. Kim HM, Hong SH, Yoo SJ, Baek KS, Jeon YJ, Choun SY. 2006. Differential effects of chitooligosaccharides on serum cytokine levels in aged subjects. J Med Food. 9:427-430.
5. Lacativa PG, Farias ML. 2010. Osteoporosis and inflammation. Arq Bras Endocrinol Metabol. 54:123-132.
6. Laveti D, Kumar M, Hemalatha R, Sistla R, Naidu VG, Talla V, Verma V, Kaur N, Nagpal R. 2013. Anti-inflammatory treatments for chronic diseases: a review. Inflamm Allergy Drug Targets. 12:349-361.
7. Lee SH, Senevirathne M, Ahn CB, Kim SK, Je JY. 2009. Factors affecting anti-inflammatory effect of chitooligosaccharides in lipopolysaccharides-induced RAW264.7 macrophage cells. Bioorg Med Chem Lett. 19:6655-6658.
8. Ma Z, Bai L. 2012. The anti-inflammatory effect of Z-Ligustilide in experimental ovariectomized osteopenic rats. Inflammation. 35:1793-1797.
9. Pagani F, Francucci CM, Moro L. 2005. Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest. 28:8-13.
10. Pangestuti R, Bak SS, Kim SK. 2011. Attenuation of pro-inflammatory mediators in LPS-stimulated BV2 microglia by chitooligosaccharides via the MAPK signaling pathway. Int J Biol Macromol. 49:599-606.
11. Richards JB, Joseph L, Schwartzman K, Kreiger N, Tenenhouse A, Goltzman D, Canadian Multicentre Osteoporosis Study Group. 2006. The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 17:1410-1419.
12. Venkatesan J, Pangestuti P, Qian ZJ, Ryu B, Kim SK. 2010. Biocompatibility and alkaline phosphatase activity of phosphorylated chitooligosaccharides on the osteosarcoma MG63 cell Line. J Funct Biomater. 1:3-13.
13. Wang P, Li XT, Sun L, Shen L. 2013. Anti-inflammatory activity of water-soluble polysaccharide of Agaricus blazei Murill on ovariectomized osteopenic rats. Evid Based Complement Alternat Med. 2013:164817.